Human brucellosis remains a significant public health issue in the Ili Kazak Autonomous Prefecture, Xinjiang, China. To assist local Centers for Disease Control and Prevention (CDC) in promptly formulate effective prevention and control measures, this study leveraged time-series data on brucellosis cases from February 2010 to September 2023 in Ili Kazak Autonomous Prefecture. Three distinct predictive modeling techniques—Seasonal Autoregressive Integrated Moving Average (SARIMA), eXtreme Gradient Boosting (XGBoost), and Long Short-Term Memory (LSTM) networks—were employed for long-term forecasting. Further, the optimal model will be used to explore the impact of COVID-19 on the transmission of Human brucellosis in the region. We constructed a SARIMA(4,1,1)(3,1,2)12 model, an XGBoost model with a time lag of 22, and an LSTM model featuring 3 LSTM layers and 100 neurons in the fully connected layer to predict monthly reported cases from January 2021 to September 2023. The results indicated that the occurrence of brucellosis exhibits pronounced seasonal patterns, with higher incidence during summer and autumn, peaking in June annually. Performance evaluations revealed low Mean Absolute Error (MAE), Root Mean Square Error (RMSE), and Symmetric Mean Absolute Percentage Error (SMAPE) for all three models. Specifically, the coefficient of determination (R2) was 0.6177 for the SARIMA model, 0.8033 for the XGBoost model, and 0.6523 for the LSTM model. The study found that the XGBoost model outperformed the other two in long-term forecasting of brucellosis, demonstrating higher predictive accuracy. This discovery can aid public health departments in advancing the deployment of prevention and control resources, particularly during peak seasons of brucellosis. It was also found that the impact of the COVID-19 pandemic on the transmission of human brucellosis in the region was minimal. This research not only provides a reliable predictive tool but also offers a scientific basis for formulating early prevention and control strategies, potentially reducing the spread of this disease.
Diabetes retinopathy (DR) is a critical clinical disease with that causes irreversible visual damage in adults, and may even lead to permanent blindness in serious cases. Early identification and treatment of DR is critical. Our aim was to train and externally validate a prediction nomogram for early prediction of DR. 2381 patients with type 2 diabetes mellitus (T2DM) were retrospective study from the First Affiliated Hospital of Xinjiang Medical University in Xinjiang, China, hospitalised between Jan 1, 2019 and Jun 30, 2022. 962 patients with T2DM from the Suzhou BenQ Hospital in Jiangsu, China hospitalised between Jul 1, 2020 to Jun 30, 2022 were considered for external validation. The least absolute shrinkage and selection operator (LASSO) and multivariate logistic regression was performed to identify independent predictors and establish a nomogram to predict the occurrence of DR. The performance of the nomogram was evaluated using a receiver operating characteristic curve (ROC), a calibration curve, and decision curve analysis (DCA). Neutrophil, 25-hydroxyvitamin D3 [25(OH)D3], Duration of T2DM, hemoglobin A1c (HbA1c), and Apolipoprotein A1 (ApoA1) were used to establish a nomogram model for predicting the risk of DR. In the development and external validation groups, the areas under the curve of the nomogram constructed from the above five factors were 0.834 (95%CI 0.820–0.849) and 0.851 (95%CI 0.829–0.874), respectively. The nomogram demonstrated excellent performance in the calibration curve and DCA. This research has developed and externally verified that the nomograph model shows a good predictive ability in assessing DR risk in people with type 2 diabetes. The application of this model will help clinicians to intervene early, thus effectively reducing the incidence rate and mortality of DR in the future, and has far-reaching significance in improving the long-term health prognosis of diabetes patients.
Background: Diabetic peripheral neuropathy (DPN) is a critical clinical disease with high disability and mortality rates. Early identification and treatment of DPN is critical. Our aim was to train and externally validate a prediction nomogram for early prediction of DPN. Methods: 3012 patients with T2DM were retrospectively studied. These patients were hospitalized between 1 January 2017 and 31 December 2020 in the First Affiliated Hospital of Xinjiang Medical University in Xinjiang, China. A total of 901 patients with T2DM from the Suzhou BenQ Hospital in Jiangsu, China who were hospitalized between 1 January 2019 and 31 December 2020 were considered for external validation. The least absolute shrinkage and selection operator (LASSO) and multivariate logistic regression were performed to identify independent predictors and establish a nomogram to predict the occurrence of DPN. The performance of the nomogram was evaluated using a receiver operating characteristic curve (ROC), a calibration curve, and a decision curve analysis (DCA). Findings: Age, 25-hydroxyvitamin D3 [25(OH)D3], Duration of T2DM, high-density lipoprotein (HDL), hemoglobin A1c (HbA1c), and fasting blood glucose (FBG) were used to establish a nomogram model for predicting the risk of DPN. In the training and validation cohorts, the areas under the curve of the nomogram constructed from the above six factors were 0.8256 (95% CI: 0.8104–0.8408) and 0.8608 (95% CI: 0.8376–0.8840), respectively. The nomogram demonstrated excellent performance in the calibration curve and DCA. Interpretation: This study has developed and externally validated a nomogram model which exhibits good predictive ability in assessing DPN risk among the type 2 diabetes population. It provided clinicians with an accurate and effective tool for the early prediction and timely management of DPN.
Background: Diabetic peripheral neuropathy (DPN) is a prevalent and highly disabling complication of diabetes mellitus, associated with markedly increased rates of disability and mortality. Timely intervention and effective management have been consistently shown to substantially reduce the risk of DPN onset and progression. Methods: This retrospective cohort study analyzed 1, 004 hospitalized patients with type 2 diabetes mellitus (T2DM) admitted to the endocrinology department of a hospital in Jiangsu Province, China. A risk prediction model for DPN was developed using the Random Forest (RF) algorithm, while logistic regression analysis was employed to identify the major risk factors. The overarching aim was to provide a reliable risk assessment tool for clinical application. Findings: Five principal factors were identified as significantly associated with DPN risk: age (OR = 1.257, 95% CI [1.188–1.367], p < 0.001), serum 25(OH)D3 levels (OR = 0.791, 95% CI [0.759–0.854], p < 0.001), duration of diabetes (OR = 1.431, 95% CI [1.285–1.617], p < 0.001), glycated hemoglobin (HbA1c) (OR = 1.236, 95% CI [1.197–1.391], p < 0.001), and glycated serum protein (GSP) (OR = 1.091, 95% CI [1.047–1.201], p = 0.017). A DPN risk prediction model incorporating these variables achieved an area under the receiver operating characteristic curve (AUC) of 0.829 (95% CI: 0.802–0.857), demonstrating excellent discriminatory performance. Interpretation: The Random Forest–based DPN risk prediction model successfully identified five critical risk factors, offering a solid theoretical foundation for personalized strategies in DPN prevention and management among patients with diabetes. This model exhibits high predictive utility in clinical practice.
Pancreatic cancer, as a highly lethal malignant tumor, presents significant challenges for early diagnosis and treatment. Accurate segmentation of the pancreas and tumors is crucial for surgical planning and treatment strategy development. However, due to the variable morphology, blurred boundaries, and low contrast with surrounding tissues in CT images, traditional manual segmentation methods are inefficient and heavily reliant on expert experience. To address this challenge, this study proposes a lightweight automated 3D segmentation algorithm—Multi-Dimensional Decoupled Multi-Scale U-Net (MDMU-Net). First, depthwise separable convolution is employed to reduce model complexity. Second, a multi-dimensional decoupled multi-scale module is designed as the primary encoder module, which independently extracts features along depth, height, and width dimensions through parallel multi-scale convolutional kernels, achieving fine-grained modeling of complex anatomical structures. Finally, cross-dimensional channel and spatial attention mechanisms are introduced to enhance recognition capability for small tumors and blurred boundaries. Experimental results on the MSDPT and NIHP datasets demonstrate that MDMU-Net exhibits competitive advantages in both pancreatic segmentation DSC (0.7108/0.7709) and tumor segmentation DSC (showing an 11.8% improvement over AttentionUNet), while achieving a 15.3% enhancement in HD95 boundary accuracy compared to 3DUX-Net. While maintaining clinically viable precision, the model significantly improves computational efficiency, with parameter count (26.97M) and FLOPs (84.837G) reduced by 65.5% and 71%, respectively, compared to UNETR, providing reliable algorithmic support for precise diagnosis and treatment of pancreatic cancer.